簡要描述:半乳糖基轉(zhuǎn)移酶2抗體免 疫 原;KLH conjugated synthetic peptide derived from human C1GALT1C1: 181-280/318
產(chǎn)品分類
Product Category相關(guān)文章
Related Articles詳細(xì)介紹
半乳糖基轉(zhuǎn)移酶2抗體
產(chǎn)品名稱 | 英文名稱 | 貨號(hào) |
半乳糖基轉(zhuǎn)移酶2抗體 | C1GALT1C1 | GOY-01K1512 |
商品屬性:
英文名稱: C1GALT1C1
中文名:半乳糖基轉(zhuǎn)移酶2抗體
別 名;HSPC067;
3-galactosyltransferase 2; Beta 1,3 galactosyltransferase 2; Beta1,3
galactosyltransferase 2; C1Gal T2; C1Gal-T2; C1GALT1 specific chaperone 1;
C1GALT1-specific chaperone 1; C1galt1c1; C1GalT2; C1GLC_HUMAN; C38H2 L1; C38H2
like protein 1; C38H2-L1; C38H2-like protein 1; C38H2L1; Core 1 beta1; Core 1
beta3 galactosyltransferase specific molecular chaperone; Core 1 beta3-Gal-T2;
Core 1 beta3-galactosyltransferase-specific molecular chaperone; Core 1 UDP galactose:N
acetylgalactosamine alpha R beta 1,3 galactosyltransferase 2; COSMC; HSPC067;
MGC19947; MGC19947; MST143.
研究領(lǐng)域;腫瘤 細(xì)胞生物 信號(hào)轉(zhuǎn)導(dǎo) 糖蛋白 新陳代謝
抗體來源;Rabbit
克隆類型;Polyclonal
交叉反應(yīng);(predicted:
Human, Mouse, Rat, Dog, Pig, Cow, Horse, Sheep, )
產(chǎn)品應(yīng)用;WB=1:500-2000
ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 (石蠟切片需做抗原修復(fù))
not yet tested in
other applications.
optimal
dilutions/concentrations should be determined by the end user.
理論分子量;36kDa
細(xì)胞定位;細(xì)胞膜
性 狀;Liquid
濃 度;1mg/ml
免 疫 原;KLH
conjugated synthetic peptide derived from human C1GALT1C1: 181-280/318
亞 型;IgG
純化方法;affinity
purified by Protein A
緩 沖 液;0.01M
TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
注意事項(xiàng);This
product as supplied is intended for research use only, not for use in human,
therapeutic or diagnostic applications.
產(chǎn)品介紹:
This gene encodes a type II transmembrane protein
that is similar to the core 1 beta1,3-galactosyltransferase 1, which
catalyzes the synthesis of the core-1 structure, also known as
Thomsen-Friedenreich antigen, on O-linked glycans. This gene product lacks
the galactosyltransferase activity itself, but instead acts as a molecular
chaperone required for the folding, stability and full activity of the core 1
beta1,3-galactosyltransferase 1. Mutations in this gene have been associated
with Tn syndrome. Alternatively spliced transcript variants encoding the same
protein have been identified. [provided by RefSeq, Dec 2009] Probable chaperone required for the generation of
1 O-glycan Gal-beta1-3GalNAc-alpha1-Ser/Thr (T antigen), which is a precursor
for many extended O-glycans in glycoproteins. Probably acts as a specific
molecular chaperone assisting the folding/stability of core 1
beta-3-galactosyltransferase (C1GALT1). |
多克隆抗體制備:
我公司合成抗原,保證陽性血清和抗體ELISA效價(jià)達(dá)到1:32000,由蛋白抗原制備的多抗,保證WB檢測結(jié)果是陽性。技術(shù)服務(wù)實(shí)行分步報(bào)價(jià),按節(jié)點(diǎn)收費(fèi),為客戶節(jié)約成本。
鼠單克隆抗體制備:
客戶可根據(jù)項(xiàng)目實(shí)際需求情況靈活選擇進(jìn)行,我公司將為您的項(xiàng)目提供專業(yè)的建議。在制備過程中,與客戶互動(dòng)驗(yàn)證,確保最終制備的抗體ELISA陽性血清檢測達(dá)到合同要求的同時(shí),也能滿足客戶抗體最終應(yīng)用驗(yàn)證需求。技術(shù)服務(wù)實(shí)行分步報(bào)價(jià),按節(jié)點(diǎn)收費(fèi),為客戶節(jié)約成本。
重組抗體表達(dá)服務(wù):
重組抗體技術(shù)使制備人源化抗體和人源抗體成為可能,而這是其他常規(guī)的多克隆或單克隆抗體制備方法無法做到的。我公司已搭建好的抗體測序、重組抗體表達(dá)等先進(jìn)平臺(tái),能為客戶提供各種類型的重組抗體表達(dá)服務(wù),包含鼠源單克隆抗體構(gòu)建及表達(dá)、更換恒定區(qū)亞型的嵌合抗體表達(dá),抗體人源化改造及表達(dá)等服務(wù)。
單項(xiàng)免疫學(xué)及檢測服務(wù):
我公司也為客戶提供單項(xiàng)免疫學(xué)和檢測服務(wù),如動(dòng)物免疫、動(dòng)物飼養(yǎng)、抗體修飾服務(wù)(如FITC,HRP等的標(biāo)記)、以及ELISA,WB,IHC,DB等檢測服務(wù)。
抗體定制服務(wù):
已注冊(cè)商標(biāo),主要用于抗體藥物發(fā)現(xiàn)和開發(fā),是我公司針對(duì)有特定應(yīng)用要求和各種模型測試的客戶量身定制的專業(yè)服務(wù),主要面向工業(yè)客戶。
產(chǎn)品咨詢
歡迎您關(guān)注我們的微信了解更多信息
電話
微信掃一掃